ATPγS (tetralithium salt)


CAS No. : 93839-89-5

(Synonyms: Adenosine-5'-O-(3-thiotriphosphate) (tetralithium salt); Adenosine 5'-[γ-thio]triphosphate (tetralithium salt))

93839-89-5
Price and Availability of CAS No. : 93839-89-5
Size Price Stock
5mg $198 In-stock
10mg $338 In-stock
25mg $720 In-stock
50mg $1250 In-stock
100mg $2150 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-108666
M.Wt: 546.98
Formula: C10H12Li4N5O12P3S
Purity: >98 %
Solubility: H2O : 75 mg/mL (ultrasonic);DMSO : 100 mg/mL (ultrasonic)
Introduction of 93839-89-5 :

ATPγS (tetralithium salt) is a P2Y11 receptor agonist, an antioxidant and a neuroprotective agent. ATPγS (tetralithium salt) can be used as a substrate for the nucleotide hydrolysis and RNA unwinding activities of eukaryotic translation initiation factor eIF4A. ATPγS (tetralithium salt) is active in ATP hydrolysis[1][2][3][4][5]. In Vitro:ATPγS (tetralithium salt) enhances intrinsic fluorescence and induces aggregation which increases the activity of spinach Rubisco activase[1].
ATPγS (50-100 μM final blood concentration) attenuates inflammatory response with decreased accumulation of cells (48%, P < 0.01) and proteins (57%, P < 0.01) in bronchoalveolar lavage and reduces neutrophil infiltration and extravasation of Evans blue albumin dye into lung tissue[3].
In Vivo:ATPγS (tetralithium salt, 50 μM final, intravenous) demonstrates preserved lung parenchymal architecture[3].
ATPγS results in a dose-dependent effect on EBA extravasation in LPS-treated mice[3].

Your information is safe with us.